A recent analysis of patients with AMI revealed that elevated levels of galectin-3 were associated with a 4.4 times higher risk of developing atrial fibrillation, suggesting that Gal-3 could be a prognostic biomarker in acute myocardial infarction. Here, LGALS3 is linked to atrial fibrillation.